Jump to any asset
849 assets, updated daily
As of October 10, 2026, Rocket Lab Corporation (RKLB) trades at $68.21. CleaRank Financial AI rates it Buy with a fair value of $68.21, in line with the current price. Wall Street's consensus target is $110.00 across 21 analysts. RSI at 47 is in neutral territory, and the price is below its 50-day average of $70.53.
Rocket Lab Corporation (RKLB)
Rocket Lab Corporation NASDAQ
$68.21
-0.1900 (-0.28%)
At close: Oct 9, 4:00 PM EDT
AI Analyst Consensus
75 / 100
Rocket Lab Corporation (RKLB) is currently trading at $68.21, below its 50-day and 200-day moving averages ($70.53 and $81.61). The company is experiencing significant insider selling, with over $972 million in sales versus no reported purchases, indicating potential near-term headwinds. Despite this, Wall Street maintains a 'Buy' consensus, with a median price target of $110.00, suggesting a 61.3% upside potential. The company's strong revenue growth of 62% and projected growth rates of 75.9% for the current year and 223% for next year are key drivers for this optimistic outlook. Rocket Lab operates in the Aerospace & Defense sector, which has a median P/E of -252.63 and revenue growth of 11.7%. RKLB's price-to-sales ratio of 56.86 is significantly higher than the sector median of 4.0, indicating a premium valuation based on future growth expectations rather than current profitability. The company's negative profit margin of -21.51% and EPS of -0.27 highlight the current unprofitability, a key risk for investors.
RKLB Price Analysis
Market Metrics
Open
$68.71
Day Range
$66.98 to $69.25
Prev Close
$68.40
Volume
14.87M
52-Week Range
$37.57 to $151.00
Market Cap
$43.61B
Peer Benchmarking
Valuation vs Sector (Industrials)
Performance vs ITA
Sector Position Analysis
On price-to-sales, the yardstick used here in place of P/E, RKLB trades at 56.86x, far above the sector average of 4.00x.
RKLB Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 4 quarters, RKLB beat estimates 3 times. The stock rose 2 times the next day. Price tends to react positively to beats.
RKLB Analysis
Company's Health
3/5
12-Month Analyst Target
+61.27% Upside
Median of 21 analysts (12-month)
$110.00
AI Technical Analysis
Rocket Lab Corporation (RKLB) is currently trading below its 50-day and 200-day moving averages ($70.53 and $81.61), indicating a bearish short-to-medium term trend. The Relative Strength Index (RSI) is at 46.73, suggesting neutral momentum, neither overbought nor oversold. The MACD is slightly positive at 0.51, but the price's position relative to its moving averages points to downward pressure. Key support levels are not clearly defined given the limited trading history and recent price action. Volume has been below average recently, with the latest volume at 14.87 million compared to an average of 21.19 million. The stochastic indicator is low at 10.88, which could suggest a potential for a bounce, but the overall trend remains challenged by the moving average positioning.
ProTips
- Monitor insider transaction activity closely, as the recent heavy net selling of over $972 million warrants attention despite strong revenue growth projections.
- Given the current trading price is below key moving averages, consider waiting for a technical breakout or confirmation of a bottoming pattern before initiating new positions.
- The company's high price-to-sales ratio of 56.86 indicates that future growth is heavily priced in; any deceleration in revenue growth could lead to significant valuation compression.
Key Catalysts
Bullish
Strong Revenue Growth Projections
Analysts project revenue growth of 75.9% for the current year and 223% for next year, indicating significant market adoption and expansion for Rocket Lab's launch and space systems.
Source: Wall Street EstimatesBullish
Positive Analyst Consensus and Price Targets
The majority of Wall Street analysts maintain a 'Buy' rating with a median price target of $110.00, suggesting a potential 61.3% upside from the current stock price.
Source: Wall Street SummaryBearish
Heavy Insider Selling Activity
Insiders have sold over $972 million worth of stock with no reported purchases, indicating potential concerns about near-term valuation or future performance.
Source: Insider TransactionsBearish
Current Unprofitability
Rocket Lab continues to report negative EPS and profit margins, making its high valuation dependent on future growth materializing as expected.
Source: Company FundamentalsMarket Outlook
Rocket Lab Corporation (RKLB) is expected to continue its strong revenue growth trajectory over the next 12-18 months, driven by its expanding launch services and space systems capabilities. The company's projected revenue growth of 75.9% for the current year and 223% for next year underpins the optimistic analyst consensus. The median analyst price target of $110.00 suggests a substantial upside from the current price, reflecting confidence in the company's long-term potential. However, the path to profitability remains a key concern. Investors should monitor the company's ability to manage its expenses and convert its high revenue growth into positive earnings. Significant insider selling and a high valuation relative to current fundamentals are risks that could temper performance if growth falters or if profitability targets are missed. A catalyst for a re-rating could be a clear path to positive EPS or a significant reduction in the insider selling trend.
Key Statistics
| Market Cap | 43.61B |
|---|---|
| P/E Ratio | N/A (Negative EPS) |
| EPS (TTM) | -0.2700 |
| Dividend Yield | 0.00% |
| 52 Week High | 151.00 |
| 52 Week Low | 37.57 |
Rocket Lab Corporation (RKLB) exhibits a high valuation with a price-to-sales ratio of 56.86, significantly exceeding the Industrials sector median of 4.0. This premium valuation is supported by exceptional projected revenue growth, with estimates for the current year at 60.00% and next year at 42.00%, far surpassing the sector average of 11.7%. The company is currently unprofitable, reporting a negative net profit margin of -21.51% and a negative EPS of -0.27. Its return on equity is also negative at -7.92%. While the debt-to-equity ratio is low at 0.04, indicating minimal leverage, the lack of current profitability and high valuation multiples present a significant risk. Investors are betting heavily on future growth to justify the current market capitalization.
Earnings & Growth Analysis
Rocket Lab Corporation (RKLB) reported an EPS of -0.08 for the quarter ending June 2026, matching analyst estimates with no surprise. This follows a pattern of mostly meeting or beating estimates in recent quarters, with a notable 12.5% EPS surprise in the quarter ending March 2026, which coincided with a significant 34.22% price increase. The company's revenue growth remains strong, with estimates for the next quarter at +50.00% year-over-year.
Key Risks
The most significant risk for Rocket Lab Corporation (RKLB) is the heavy insider selling, with over $972 million in dispositions, signaling a potential lack of confidence from management in the near term. The company's current unprofitability, evidenced by a -21.51% net profit margin and negative EPS, combined with a high price-to-sales ratio of 56.86, presents a substantial valuation risk if growth projections are not met. Also, the stock is trading below key moving averages, indicating technical weakness. Investors should closely monitor future earnings reports and management commentary for signs of a path to profitability and sustained revenue acceleration to justify the current premium valuation.
Technical Indicators
| RSI (14) | 46.73 |
|---|---|
| MACD | 0.51 |
| SMA 50 | 70.53 |
| SMA 200 | 81.61 |
RSI
Neutral
SMA Cross
Bearish
Price vs SMA
Bearish
MACD
Bullish
Moving averages show a lagging Death Cross (50-day: $70.53, 200-day: $81.61), price is trading below the 50-day SMA.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.47
Moderate correlation
Nasdaq 100 (QQQ)
+0.50
Moderate correlation
Bitcoin (BTC)
+0.39
Weak correlation
Gold (XAU)
+0.20
Weak correlation
Check Custom Correlation
How does any other asset move with RKLB? One year of daily closes, Pearson correlation.
Try
RKLB Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Long entry pick an entry style
Conservative
$66.85
2% below current price (Pullback entry)
Lower risk, wait for pullback
Aggressive
$68.21
Buy at current price
Higher risk, immediate entry
Risk Management
STOP LOSS
$63.45
MAX LOSS
-5.1%
Volatility-Adjusted Stop Loss
Calculated based on RSI (46.7) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$70.19
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$73.53
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$76.87
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
High-Volatility Risk Disclaimer
RKLB is classified as a high-volatility asset (Daily Vol: 3.23%). Aggressive price swings can lead to rapid capital loss. Liquidity risks may prevent exiting trades at desired prices. This AI-generated analysis is for educational purposes only and is not financial advice. Generated on October 10, 2026.Growth of $10,000
A $10,000 investment in RKLB in November 2020 would be worth about $70,002 today, compared with about $21,435 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in RKLB today could grow to about $49,944 by 2036 in the base case, with a bull case near $378,905 and a bear case around $6,583. Projections are statistical simulations, not guarantees.
RKLB Stock Price Prediction: 2030
CleaRank's simulation projects a price near $130 for RKLB by 2030 in the base case, from $68.21 today (1.9x over 4 years). The downside path ends near $36.03. These are outcomes of a Monte Carlo simulation run on RKLB's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $42.21 | $80.11 | $152 |
| 2028 | $38.02 | $94.09 | $233 |
| 2029 | $36.42 | $111 | $335 |
| 2030 | $36.03 | $130 | $468 |
| 2031 | $36.37 | $152 | $639 |
| 2032 | $37.26 | $179 | $860 |
| 2033 | $38.59 | $210 | $1,146 |
| 2034 | $40.32 | $247 | $1,513 |
| 2035 | $42.42 | $290 | $1,983 |
| 2036 | $44.90 | $341 | $2,585 |
Method: 10,000 simulated price paths using RKLB's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. RKLB is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
RKLB Insider Trading Analysis
Bought
None
No open-market buys
Sold
$972.2M
60 Transactions
Insiders
15
Active Traders
Avg Transaction
$16.2M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 8, 2026 | BECK PETER
Chief Executive Officer
|
Sell | 3.3M | $286.4M |
| Dec 16, 2025 | BECK PETER
Chief Executive Officer
|
Sell | 2.5M | $141.1M |
| Sep 16, 2025 | BECK PETER
Chief Executive Officer
|
Sell | 2.5M | $127.5M |
| Jan 5, 2026 | SPICE ADAM C
Chief Financial Officer
|
Sell | 1.4M | $103.1M |
| Nov 15, 2024 | OCKO MATTHEW A
Director
|
Sell | 5.4M | $96.8M |
| Sep 16, 2025 | OCKO MATTHEW A
Director
|
Sell | 1.9M | $90.3M |
| Sep 19, 2025 | SPICE ADAM C
Chief Financial Officer
|
Sell | 874.6K | $42.0M |
| Jun 13, 2025 | OCKO MATTHEW A
Director
|
Sell | 1.0M | $26.6M |
| Sep 11, 2023 | BECK PETER
Chief Executive Officer
|
Sell | 3.6M | $20.2M |
| May 27, 2026 | KAMPANI ARJUN E
General Counsel
|
Sell | 98.7K | $14.2M |
Page 1 of 1
Frequently Asked Questions
What is Rocket Lab's stock price prediction for 2030?
Based on Monte Carlo simulations, Rocket Lab's (RKLB) projected price range for 2030 is between $36.03 and $467.55, with a base case of $129.79. These figures represent statistical outcomes and are not guaranteed price targets.
Is Rocket Lab Corporation (RKLB) stock a buy right now?
Wall Street analysts have a consensus 'Buy' rating on Rocket Lab (RKLB), with a median price target of $110.00, implying a 61.3% upside from the current price of $68.21. However, significant insider selling and current unprofitability are key risks to consider.
What are the main risks facing Rocket Lab (RKLB)?
Key risks for Rocket Lab (RKLB) include heavy insider selling totaling over $972 million, current unprofitability with a -21.51% net profit margin, and a high price-to-sales ratio of 56.86 which relies heavily on future growth.
How does Rocket Lab's valuation compare to its sector?
Rocket Lab (RKLB) trades at a price-to-sales ratio of 56.86, significantly higher than the Industrials sector median of 4.0. This premium is driven by its projected high revenue growth, as the company is currently unprofitable with a negative profit margin.
What is Rocket Lab's recent earnings performance?
Rocket Lab (RKLB) recently reported an EPS of -0.08 for the quarter ending June 2026, in line with estimates. The company has shown a history of meeting or beating EPS estimates, and revenue growth remains a strong point, with next quarter's revenue expected to grow 50.00% year-over-year.
What is the outlook for Rocket Lab's revenue growth?
Rocket Lab (RKLB) is projected to achieve strong revenue growth, with estimates of 75.9% for the current year and 223% for next year. Next quarter's revenue is expected to increase by 50.00% year-over-year, indicating continued expansion.
What is the sentiment from Wall Street analysts on RKLB?
Wall Street analysts collectively rate Rocket Lab (RKLB) as a 'Buy', with 4 Strong Buys, 13 Buys, and 4 Holds, contributing to a Wall Street score of 75 out of 100. The median price target of $110.00 suggests significant upside potential.